Eric Dishman, vice president and fellow of the Health and Life Sciences Group of Intel Corp., has been selected to lead the National Institutes of Health’s landmark longitudinal study of one million or more U.S. volunteers who will make genomic and other data available to researchers.

As director of the Precision Medicine Initiative cohort program, Dishman will lead a new model of research in which participants are at the center of the effort to advance health and improve treatments for disease, according to NIH.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access